D.E. Shaw & Co’s Exelixis EXEL Stock Holding History

D.E. Shaw & Co’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-50,000	Closed	-$1.08M	–	3409
2017 Q1	$1.08M	Buy	+50,000	New	+$1.02M	﹤0.01%	2252

Other funds holding EXEL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co's EXEL Position: Q2 2026 in Review

D.E. Shaw & Co increased its Exelixis (EXEL) stake by 54% in Q2 2026, buying an estimated $94.9M and bringing the position to 5,551,747 shares worth $302M. The position accounts for 0.14% of the portfolio, ranked #131.

D.E. Shaw & Co first reported a position in EXEL in Q2 2013 and has held it in 51 quarters since. 759 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

D.E. Shaw & Co held 5,551,747 shares of Exelixis worth $302M as of Q2 2026.
D.E. Shaw & Co bought 1,948,684 Exelixis shares in Q2 2026, an estimated $94.9M.
Exelixis made up 0.14% of D.E. Shaw & Co's portfolio in Q2 2026, its #131 holding.
D.E. Shaw & Co first reported a position in Exelixis in Q2 2013 and has held it in 51 quarters since.
759 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.